Show simple item record

dc.contributor.editorSchnebly, Risa Ariaen_US
dc.creatorDarby, Alexisen_US
dc.date.accessioned2021-08-04T22:15:36Zen_US
dc.date.available2021-08-04T22:15:36Zen_US
dc.date.created2021-08-04en_US
dc.identifier.urihttps://hpsrepository.asu.edu/handle/10776/13302en_US
dc.description.abstractOn 20 August 2007, in Frazer v. Schlegel, the United States Court of Appeals for the Federal Circuit decided that researchers Ian Frazer and Jian Zhou owned the rights to the vaccine patent for Human Papillomavirus, or HPV, instead of a research team led by Richard Schlegel. Frazer v. Schlegel reversed the decision that the Board of Patent Appeals and Interferences had previously made, awarding the patent to Schlegel on the basis that Frazer’s patent application contained inaccurate science. However, once appealed, the Federal Circuit judges found Frazer’s science to be accurate, granting him rights to the vaccine patent. In 2006, the US Food and Drug Administration, or FDA, approved the first HPV vaccine, which has since been effective in protecting women from cervical cancer by up to ninety-seven percent if they were vaccinated before contracting HPV. The Circuit’s decision gave Frazer ownership of the patent for the HPV vaccine, which physicians have administered over 120 million doses of to people in the US.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_USen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subjectLawen_US
dc.subject.lcshFrazer, I. H. (Ian H.)en_US
dc.subject.lcshZhou, Jianen_US
dc.subject.lcshSchlegel, Richarden_US
dc.subject.lcshMercken_US
dc.subject.lcshGlaxoSmithKlineen_US
dc.subject.lcshLaw--United States (General)--Intellectual property--Patent law and trademarks--Patent law--Infringementen_US
dc.subject.lcshBoard of Patent Appeals and Interferencesen_US
dc.subject.lcshPatent Trial and Appeal Boarden_US
dc.subject.lcshUnited States. Court of Appeals (Federal Circuit) Federal law on disc. Court of Appeals, Federal Circuit : decisions of the United States Court of Appeals for the Federal Circuiten_US
dc.subject.lcshUnited States, Food and Drug Administrationen_US
dc.subject.lcshZur Hausen, Haralden_US
dc.subject.lcshHuman papillomavirus (HPV)-associated oropharyngeal canceren_US
dc.subject.meshHuman papillomavirus 16en_US
dc.subject.meshPapillomavirus Infectionsen_US
dc.subject.meshHPV Infectionen_US
dc.subject.meshHuman papillomavirus 18en_US
dc.subject.meshPapillomavirus Vaccinesen_US
dc.subject.meshHPV Vaccineen_US
dc.subject.meshHPV Vaccinesen_US
dc.subject.meshHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18en_US
dc.subject.meshHPV L1 Vaccine, Quadrivalent 6,11,16,18en_US
dc.subject.meshApolipoprotein L1en_US
dc.subject.meshVaccines, Virus-Like Particleen_US
dc.subject.meshViral Particleen_US
dc.subject.meshVirus-Like Particle Vaccineen_US
dc.subject.meshUterine Cervical Neoplasmsen_US
dc.subject.meshCervical Canceren_US
dc.subject.meshCancer of Cervixen_US
dc.titleFrazer v. Schlegel (2007)en_US
dc.typeArticleen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoLegalen_US
dc.subject.embryoTechnologiesen_US
dc.subject.tagVLP Vaccineen_US
dc.subject.tagCancer vaccineen_US
dc.subject.tagHPV Vaccine patenten_US
dc.description.typeArticlesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record